Compare TCOM & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCOM | GEHC |
|---|---|---|
| Founded | 1999 | 1892 |
| Country | Singapore | United States |
| Employees | 41073 | N/A |
| Industry | Hotels/Resorts | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 35.8B |
| IPO Year | N/A | 2022 |
| Metric | TCOM | GEHC |
|---|---|---|
| Price | $52.26 | $72.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $78.75 | ★ $90.83 |
| AVG Volume (30 Days) | ★ 3.1M | 2.7M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 0.58% | 0.20% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $15.65 | $7.06 |
| Revenue Next Year | $12.92 | $4.50 |
| P/E Ratio | ★ $9.06 | $15.55 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $49.48 | $57.65 |
| 52 Week High | $79.00 | $89.77 |
| Indicator | TCOM | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 32.63 |
| Support Level | $49.48 | $69.64 |
| Resistance Level | $54.24 | $74.29 |
| Average True Range (ATR) | 1.17 | 2.04 |
| MACD | 0.41 | -1.00 |
| Stochastic Oscillator | 59.61 | 17.25 |
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).